Confidential Disclosure Agreement Sample Contracts
ARTICLE I DEFINITIONSConfidential Disclosure Agreement • April 26th, 2004 • Celerity Group Inc • Semiconductors & related devices • California
CONFIDENTIAL DISCLOSURE AGREEMENT (BILATERAL)Confidential Disclosure Agreement • October 6th, 2021
This Confidential Disclosure Agreement (the “Agreement”) made as of INSERT EFFECTIVE DATE (the “Effective Date”) by and between the Regents of the University of Colorado, a body corporate, contracting on behalf of the University of Colorado Colorado Springs having its principal office at 1420 Austin Bluffs Parkway, Colorado Springs, CO 80918 (hereinafter “University”), and INSERT COMPANY NAME (hereinafter, "Company"), having its principal place of business at INSERT ADDRESS
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • February 23rd, 2023
This Confidential Disclosure Agreement (“Agreement”) is effective as of the date of the last party to sign this Agreement (“Effective Date”)
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • June 30th, 2020 • Florida
This AGREEMENT, with an effective date as of this day of , 20 (“Effective Date”) is between The University of South Florida Board of Trustees, a public body corporate (Discloser) having an address at 3802 Spectrum Boulevard, Suite 100, Tampa, Florida 33612 and
Confidential Disclosure AgreementConfidential Disclosure Agreement • December 23rd, 2020 • Pennsylvania
THIS AGREEMENT, entered into and effective this ____ day of _____________, 2017, by and between Lehigh University, having a place of business at 354 Whitaker Laboratory, 5 E. Packer Ave., Bethlehem, PA 18015 (hereinafter referred to as "LEHIGH") and _____________, having a place of business at _________________________________ (hereinafter referred to as “Company”).
Confidential Disclosure Agreement This agreement is made and entered into by and between: and AND ANDConfidential Disclosure Agreement • February 20th, 2025
Where appropriate each of these Parties will hereinafter individually be referred to as “Party”, “Disclosing Party” or “Receiving Party”, and collectively be referred to as the “Parties”.
NORTH CAROLINA STATE UNIVERSITY CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • November 11th, 2024
WHEREAS, NORTH CAROLINA STATE UNIVERSITY (the UNIVERSITY or NCSU) has certain confidential information relating to “________________________” (hereinafter referred to as “NCSU's INFORMATION”) and desires to disclose the same to_____________________ (the "COMPANY"), and;
CONFIDENTIAL DISCLOSURE AGREEMENT FOR STRATEGIC MATTERSConfidential Disclosure Agreement • May 16th, 2016 • Opower, Inc. • Services-prepackaged software • California
This Confidential Disclosure Agreement (“Agreement”) is entered into as of the effective date listed below (“Effective Date”) by Oracle Corporation (“Oracle”) located at 500 Oracle Parkway, Redwood City, California 94065 and the company designated below (“Company”).
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • September 9th, 2022 • Minnesota
, United States ("Undersigned"). Each of the Undersigned and Medtronic are a "Party" and collectively the "Parties" under this Agreement.
ContractConfidential Disclosure Agreement • December 13th, 2024
CONFIDENTIAL DISCLOSURE AGREEMENT LLC «OTP Leasing» 43 Zhylianska Str, Kyiv, 01033 (hereinafter- disclosing party) ______________________(hereinafter- receiving party WHEREAS, the parties desire to exchange certain technical and/or business information and/or documents, with the purpose of facilitating negotiation related to settlement debt portfolio of the disclosing party, (the “Purpose”). WHEREAS, during the course of such discussions, the parties and their Affiliates (as defined in Section 5 below) may exchange valuable information and samples which they consider proprietary and confidential. NOW, THEREFORE, the parties agree that the following terms and conditions apply to the disclosure of such information and documents: “Confidential Information” shall mean any information disclosed, directly or indirectly, by one party to the other related to the Purpose, provided that the disclosing party identifies such information as confidential at the time of its disclosure
CONFIDENTIAL DISCLOSURE AGREEMENT – PROPOSED COLLABORATIONConfidential Disclosure Agreement • May 16th, 2018
This Confidential Disclosure Agreement (this “Agreement”) is made as of the __ day of _____________, ____ (“Effective Date”) by and between __________________________, a company (“Company”), and _________________________ (“Investigator”), an Investigator of the Howard Hughes Medical Institute (“HHMI”) and a faculty member of ____________________________ (“University”).
FIRST AMENDMENT TO CONFIDENTIAL DISCLOSURE AGREEMENT DATED 22 SEPTEMBER 2016Confidential Disclosure Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances
This First Amendment (the “Amendment”) to the Confidential Disclosure Agreement, dated 22 September 2016 (the “Agreement”), between ABT Innovations (“COMPANY”) and iFyber LLC (“IFYBER”), is entered into as of 18 May 2021.
Confidential disclosure agreementConfidential Disclosure Agreement • January 9th, 2019
The presentation of the assignment must be with "closed doors", i.e. only the supervisor, the external examiner and the student(s) must be present.
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • December 22nd, 2016 • Delaware
This Confidential Disclosure Agreement (“Agreement”) is effective as of the date of the last party to sign this Agreement (“Effective Date”)
CONFIDENTIAL DISCLOSURE AGREEMENT FOR STRATEGIC MATTERSConfidential Disclosure Agreement • March 9th, 2007 • Oracle Corp • Services-prepackaged software • California
This Confidential Disclosure Agreement (“Agreement”) is entered into as of the effective date listed below (“Effective Date”) by Oracle Corporation (“Oracle”) located at 500 Oracle Parkway, Redwood City, California 94065 and the company designated below (“Company”).
Confidential Disclosure Agreement – One CompanyConfidential Disclosure Agreement • April 19th, 2012
a legal entity created by Agreement between the Government of the State of Israel and the Government of the United States of America located at Kiryat Atidim, Building 4, Tel Aviv, 61581, Israel (hereinafter referred to as the "Foundation"),.
CONFIDENTIAL DISCLOSURE AgreementConfidential Disclosure Agreement • March 19th, 2024
This Confidential Disclosure Agreement (the “Agreement”) is made on the date of last signature (the “Effective Date”) between:
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • October 12th, 2017
THIS AGREEMENT is made effective the day of , 2020 by and between Pasco Economic Development Council, Inc. (Pasco EDC) and (“Company/Member”).
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • November 11th, 2014
This Confidential Disclosure Agreement is made as of (MM/DD/YR; the “Effective Date”) between The University of Maryland, Baltimore (“Provider”) and
Confidential Disclosure Agreement Request FormConfidential Disclosure Agreement • June 19th, 2017
CONFIDENTIAL DISCLOSURE AGREEMENT – PROPOSED CONSULTINGConfidential Disclosure Agreement • May 16th, 2018
This Confidential Disclosure Agreement (this “Agreement”) is made as of the __ day of ______, _____ (“Effective Date”) by and between __________________________, a company (“Company”), and _________________________ (“Investigator”), an Investigator of the Howard Hughes Medical Institute (“HHMI”) and a faculty member of ____________________________ (“University”).
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • March 22nd, 2022
This Confidential Disclosure Agreement (the “CDA”) is made as of , 202_ (the “Effective Date”) by and between the Regents of the University of Colorado, a body corporate, for and on behalf of the University of Colorado Denver, a public institution of higher education created under the Constitution and the Law of the State of Colorado (“Institution”) and [ ] (“Discloser”).
AMENDMENT NO. 2 TO THE CONFIDENTIAL DISCLOSURE-IN AGREEMENTConfidential Disclosure Agreement • March 12th, 2021 • Pandion Therapeutics, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 2 TO THE CONFIDENTIAL DISCLOSURE AGREEMENT (this “Amendment No. 2”) is entered into as of December 18, 2020 (the “Amendment No. 2 Effective Date”), confirms the mutual understanding between Merck Sharp & Dohme Corp., having a place of business at 33 Avenue Louis Pasteur, Boston, Massachusetts 02115 USA (“Merck”) and Pandion Therapeutics, Inc., having a place of business at 134 Coolidge Ave., Watertown, MA 02472 (“Discloser”). Merck and the Discloser may be referred to herein individually as a “Party” or together as the “Parties”.
CONFIDENTIAL DISCLOSURE AGREEMENT Agreement dated ________________, between Institution, a [ ] non-profit organization having its principal place of business at [ ] ("School"), and [ ] a [ ] corporation, with a principal place of business at [...Confidential Disclosure Agreement • October 30th, 2020
ORACLE® AMENDMENT NO. 1 TO CONFIDENTIAL DISCLOSURE AGREEMENT FOR STRATEGIC MATTERSConfidential Disclosure Agreement • January 19th, 2022 • CERNER Corp • Services-computer integrated systems design
This Amendment No. 1 (“Amendment”) to the Confidential Disclosure Agreement For Strategic Matters (“Agreement”), dated as of October 15, 2021, by and between Oracle Corporation (“Oracle”) located at 500 Oracle Parkway, Redwood City, California 94065 and Cerner Corporation (“Company”), is entered into by the parties as of the effective date listed below (“Amendment Effective Date”) and amends the Agreement as follows:
Confidential Disclosure AgreementConfidential Disclosure Agreement • June 16th, 2021 • Massachusetts
During the term of the Agreement, each party may disclose certain confidential information to the other party so that the parties may determine their interest in entering into a working relationship with each other, as well as evaluating or otherwise negotiating such working relationship or consummating a transaction (the “Transaction”), related to any technology or research of the laboratory of University of Massachusetts Medical School.
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • February 6th, 2022
This Confidential Disclosure Agreement (“Agreement”) will confirm the mutual interest of (”Recipient”), located at _____________________and National Health Research Institutes (“NHRI”), located at 35, Keyan Road, Zhunan Town, Miaoli County 350, Taiwan, R.O.C. in disclosing to Recipient certain proprietary information for the purpose of exploring the possibility of a commercial arrangement relating to [pls insert subject matter] (the “Purpose”). NHRI shall disclose to Recipient information relating to [pls insert subject matter] (“ Confidential Information”)(Appendix [pls insert number or code]). Recipient will receive and evaluate the Confidential Information received from NHRI under the following terms and conditions:
Confidential Disclosure AgreementConfidential Disclosure Agreement • December 14th, 2015
This agreement made and entered into this day of , , by and between RITALKA, Inc., subsidies’ SpecSys, Inc. and RVI-Inc., whose address is 121 North 1st Street, Suite 201 Montevideo, MN 56265, (hereinafter referred to as “Discloser”), and
Confidential Disclosure AgreementConfidential Disclosure Agreement • October 7th, 2019
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • January 30th, 2025
This Confidential Disclosure Agreement (the “Agreement”) is made effective on the date of the last signature (the "Effective Date"), between NOUSCOM AG, a limited company organised under the laws of Switzerland, with registered number CH-270.4.004.029-6 with registered offices at Bäumleingasse 18, 4051, Basel, Switzerland and its Affiliates (“NOUSCOM”)
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • November 23rd, 2021 • Delaware
THIS CONFIDENTIAL DISCLOSURE AGREEMENT (the “Agreement”) is made as of the last dated signature below (the “Effective Date”) by and between Dicerna Pharmaceuticals Inc., a Delaware corporation with a business address at 33 Hayden Avenue, Lexington, Massachusetts 02421 (Tel: 617-621-8097; Fax: 6l7-252-0976)(“Dicerna”), and Novo Nordisk A/S, with a business address at Novo Alle I, 2880 Bagsvaerd, Denmark (“COMPANY”) (each a “Party” and, collectively, the “Parties”).
ContractConfidential Disclosure Agreement • December 6th, 2016
Title: Confidential Disclosure Agreements/CDA (Industry Sponsored) Relates to Policy/Procedure:301-12 302-12 SOP#: 300-12 Version 2.0 Prepared by: J. Kulko, MS, MSN Original date: June 28, 2012 Approved by: J. Kulko, MS, MSN Date approved: August 19, 2016
Exhibit 3 CONFIDENTIAL DISCLOSURE AGREEMENT This Confidential Disclosure Agreement is entered into as of the 11th day of January, 1999, by and between Endogen, Inc., a Massachusetts Corporation (the "Disclosing Party") and Pierce Chemical Co. (the...Confidential Disclosure Agreement • June 2nd, 1999 • Endogen Inc • In vitro & in vivo diagnostic substances • Massachusetts
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • May 25th, 2022
by and between the Regents of the University of Colorado, a body corporate, for and on behalf of the University of Colorado Boulder, a public institution of higher education created under the Constitution and the Law of the State of Colorado (“Institution”) and
CONFIDENTIAL DISCLOSURE AGREEMENTConfidential Disclosure Agreement • June 28th, 2019 • Pfizer Inc • Pharmaceutical preparations • New York
Pfizer Inc., a corporation organized and existing under the laws of Delaware, with offices at 235 East 42nd Street, New York, New York 10017 (“Pfizer”); and